Lalitha R Belur

Title: Lalitha R Belur: Innovator in Gene Therapy

Introduction

Lalitha R Belur is a prominent inventor based in Saint Paul, MN (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of rare genetic disorders. With a total of 2 patents, his work focuses on innovative methods to address critical health challenges.

Latest Patents

Belur's latest patents include groundbreaking methods to treat mucopolysaccharidosis type II, utilizing a recombinant adeno-associated virus (AAV) vector that encodes iduronate-2-sulfatase. This method aims to prevent, inhibit, or treat symptoms associated with central nervous system diseases by administering rAAV encoding a gene product linked to the disease. Additionally, he has developed methods to treat mucopolysaccharide type I, employing a similar approach with alpha-L-iduronidase.

Career Highlights

Throughout his career, Lalitha R Belur has worked with esteemed organizations such as the University of Minnesota and Regenxbio Inc. His research has been pivotal in advancing therapeutic strategies for genetic disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Belur has collaborated with notable professionals in his field, including R Scott McIvor and Walter C Low. These partnerships have further enriched his research and innovation efforts.

Conclusion

Lalitha R Belur stands out as a key figure in the realm of gene therapy, with his innovative patents and collaborations paving the way for future advancements in treating genetic disorders. His contributions continue to inspire and impact the medical community.